<SEC-DOCUMENT>0001677077-17-000001-index.html : 20170822
<SEC-HEADER>0001677077-17-000001.hdr.sgml : 20170822
<ACCEPTANCE-DATETIME>20170822165718
ACCESSION NUMBER:		0001677077-17-000001
CONFORMED SUBMISSION TYPE:	D
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		<ITEMS>06b
FILED AS OF DATE:		20170822
DATE AS OF CHANGE:		20170822
EFFECTIVENESS DATE:		20170822

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Alzamend Neuro, Inc.
		CENTRAL INDEX KEY:			0001677077
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				811822909
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		D
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-293300
		FILM NUMBER:		171045642

	BUSINESS ADDRESS:	
		STREET 1:		50 W. BROADWAY
		STREET 2:		3RD FLOOR
		CITY:			SALT LAKE CITY
		STATE:			X1
		ZIP:			84101
		BUSINESS PHONE:		9493465822

	MAIL ADDRESS:	
		STREET 1:		50 W. BROADWAY
		STREET 2:		3RD FLOOR
		CITY:			SALT LAKE CITY
		STATE:			X1
		ZIP:			84101
</SEC-HEADER>
<DOCUMENT>
<TYPE>D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>